ESC 2013 schedule: Difference between revisions
Jump to navigation
Jump to search
Emily Larkin (talk | contribs) No edit summary |
Emily Larkin (talk | contribs) |
||
| (44 intermediate revisions by 2 users not shown) | |||
| Line 24: | Line 24: | ||
== Friday, August 30, 2013== | == Friday, August 30, 2013== | ||
=== | ===10:30 AM=== | ||
''10:30 AM – 11:00 AM'' | |||
*'''Interviewee:''' Dr. Philippe Gabriel Steg | |||
*'''Topic:''' TAO: Otamixaban in non-ST-segment elevation acute coronary syndrome patients undergoing a planned invasive strategy | |||
*'''Embargo lift:''' Sunday, September 1, 2013 at 11:36 AM | |||
== Saturday, August 31, 2013== | == Saturday, August 31, 2013== | ||
| Line 60: | Line 36: | ||
*'''Interviewee:''' Dr. Frank Peacock (APEX Steering Committee Member) | *'''Interviewee:''' Dr. Frank Peacock (APEX Steering Committee Member) | ||
*'''Topic:''' Challenges and Solutions in the APEX Study | *'''Topic:''' Challenges and Solutions in the APEX Study | ||
== Sunday, September 1, 2013== | == Sunday, September 1, 2013== | ||
| Line 79: | Line 43: | ||
===8:30 AM=== | ===8:30 AM=== | ||
''8:30 AM – 9:00 AM'' | |||
*'''Interviewee:''' Dr. Stephen James Nicholls | |||
*'''Topic:''' ASSURE: Effect of an Oral Agent Inducing Apo A-I Synthesis on Progression of Coronary Atherosclerosis: Results of the ASSURE Study | |||
*'''Embargo lift:''' Monday, September 2, 2013 at 11:54 AM | |||
*'''Interviewee:''' Dr. Stephen James Nicholls | |||
*'''Topic:''' AQUARIUS: Effect of the Renin Inhibitor Aliskiren on Progression of Coronary Atherosclerosis: AQUARIUS Study Results | |||
*'''Embargo lift:''' Tuesday, September 3, 2013 at 11:54 AM | |||
===9:00 AM=== | ===9:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
=== | ===10:00 AM=== | ||
''10:00 AM – 10:30 AM'' | |||
*'''Interviewee:''' Dr. Chuck Shear | |||
*'''Topic:''' The Development of the CSL-112 Study | |||
=== | ===1:45 PM=== | ||
''1:45 PM – 2:00 PM'' | |||
*'''Interviewee:''' Dr. Bela Merkely and Dr. Toth Attila | |||
*'''Topic:''' The EMBRACE-MI Study | |||
===2:00 PM=== | ===2:00 PM=== | ||
''2:00 PM – 2:30 PM'' | |||
*'''Interviewee:''' Dr. Doug Weaver | |||
*'''Topic:''' The EMBRACE-MI Study | |||
== Monday, September 2, 2013== | == Monday, September 2, 2013== | ||
===8:00 AM=== | ===8:00 AM=== | ||
''8:00 AM – 8:30 AM'' | |||
*'''Interviewee:''' Dr. Nassir Marrouche | |||
*'''Topic:''' DECAAF Study: Delayed Enhancement – MRI determinant of successful Catheter Ablation of Atrial Fibrillation: Analysis of post ablation scar and outcome | |||
*'''Embargo lift:''' Sunday, September 1, 2013 at 2:36 PM | |||
===8:30 AM=== | ===8:30 AM=== | ||
| Line 108: | Line 85: | ||
===11:00 AM=== | ===11:00 AM=== | ||
''11:00 AM – 11:30 AM'' | |||
*'''Interviewee:''' Dr. Robert Harrington | |||
*'''Topic:''' The Development of the CSL-112 Study | |||
=== | ===12:30 PM=== | ||
''12:30 PM – 1:00 PM'' | |||
*'''Interviewee:''' Dr. Roxana Mehran | |||
*'''Topic:''' PARIS: Incidence and Impact of Dual Antiplatelet Therapy Cessation On Adverse Cardiac Events Following Percutaneous Coronary Intervention: Two-Year Results from the Patterns of Non-Adherence to Anti-Platelet Regimens In Stented Patients (PARIS) Study | |||
*'''Embargo lift:''' Sunday, September 1, 2013 at 12:12 PM | |||
===1:00 PM=== | ===1:00 PM=== | ||
| Line 126: | Line 108: | ||
===2:00 PM=== | ===2:00 PM=== | ||
2:00 PM - 2:30 PM | |||
*'''Interviewee:''' Dr. Renato Lopes | |||
*'''Topic:''' Topic: ESC Wrap-Up in Portuguese | |||
===2:30 PM=== | ===2:30 PM=== | ||
2:30 PM - 3:00 PM | |||
*'''Interviewee:''' Dr. Basil Lewis | |||
*'''Topic:''' Topic: ESC Wrap-Up in Hebrew | |||
===3:00 PM=== | ===3:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===4:00 PM=== | |||
''4:00 PM – 4:30 PM'' | |||
*'''Interviewee:''' Dr. Sergio Leonardi and Professor Diego Ardissino | |||
*'''Topic:''' ESC Wrap-Up in Italian | |||
== Tuesday, September 3, 2013== | == Tuesday, September 3, 2013== | ||
| Line 140: | Line 131: | ||
===8:30 AM=== | ===8:30 AM=== | ||
''8:30 AM – 9:00 AM'' | |||
*'''Interviewee:''' Dr. Freek Verheugt | |||
*'''Topic:''' ESC Wrap-Up from a Dutch Perspective | |||
===9:00 AM=== | ===9:00 AM=== | ||
| Line 149: | Line 142: | ||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM – 10:30 AM'' | |||
*'''Interviewee:''' Dr. Harry Buller | |||
*'''Topic:''' Treatment of venous thromboembolism, the Hokusai VTE Study | |||
*'''Embargo lift:''' Sunday, September 1, 2013 at 11:00 AM | |||
===10:30 AM=== | ===10:30 AM=== | ||
''10:30 AM – 11:00 AM'' | |||
*'''Interviewee:''' Dr. Maarten Groenink | |||
*'''Topic:''' COMPARE: Effect of losartan on aortic dilatation rate in adults with Marfan Syndrome | |||
*'''Embargo lift:''' Monday, September 2, 2013 at 12:12 PM | |||
===11:00 AM=== | ===11:00 AM=== | ||
| Line 159: | Line 158: | ||
===11:30 AM=== | ===11:30 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===12:30 PM=== | |||
''12:30 PM – 1:00 PM'' | |||
*'''Interviewee:''' Dr. Shinya Goto | |||
*'''Topic:''' ARISTOTLE Sub-Analysis: Efficacy and safety of apixaban compared with warfarin for stroke prevention in atrial fibrillation in East Asia | |||
*'''Embargo lift:''' Tuesday, September 3, 2013 at 2:00 PM | |||
===1:00 PM=== | ===1:00 PM=== | ||
| Line 164: | Line 169: | ||
===1:30 PM=== | ===1:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
| Line 176: | Line 175: | ||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM – 4:00 PM'' | |||
*'''Interviewee:''' Dr. John Teerlink | |||
*'''Topic:''' ATOMIC-AHF: Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: Results from ATOMIC-AHF | |||
*'''Embargo lift:''' Tuesday, September 3, 2013 at 11:18 AM | |||
===4:00 PM=== | ===4:00 PM=== | ||
| Line 186: | Line 188: | ||
''4:30 PM – 5:00 PM'' | ''4:30 PM – 5:00 PM'' | ||
*'''Interviewee:''' Dr. Gilles Montalescot | *'''Interviewee:''' Dr. Gilles Montalescot | ||
*'''Topic:''' The ACCOAST Trial | *'''Topic:''' The ACCOAST Trial: A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction | ||
*'''Embargo lift:''' Sunday, September 1, 2013 at 2:18 PM | *'''Embargo lift:''' Sunday, September 1, 2013 at 2:18 PM | ||
*'''Interviewee:''' Dr. Gilles Montalescot | |||
*'''Topic:''' ESC Wrap-Up in French | |||
Latest revision as of 12:13, 28 August 2013
Here is the page we will use to coordinate the TV events at ESC 2013. Open time slots are indicated below in red.
Filming location TBD.
Click on Date for Detailed Schedule
Friday, August 30, 2013
10:30 AM
10:30 AM – 11:00 AM
- Interviewee: Dr. Philippe Gabriel Steg
- Topic: TAO: Otamixaban in non-ST-segment elevation acute coronary syndrome patients undergoing a planned invasive strategy
- Embargo lift: Sunday, September 1, 2013 at 11:36 AM
Saturday, August 31, 2013
11:30 AM
11:30 AM – 12:00 PM
- Interviewee: Dr. Frank Peacock (APEX Steering Committee Member)
- Topic: Challenges and Solutions in the APEX Study
Sunday, September 1, 2013
8:00 AM
OPEN TIME SLOT
8:30 AM
8:30 AM – 9:00 AM
- Interviewee: Dr. Stephen James Nicholls
- Topic: ASSURE: Effect of an Oral Agent Inducing Apo A-I Synthesis on Progression of Coronary Atherosclerosis: Results of the ASSURE Study
- Embargo lift: Monday, September 2, 2013 at 11:54 AM
- Interviewee: Dr. Stephen James Nicholls
- Topic: AQUARIUS: Effect of the Renin Inhibitor Aliskiren on Progression of Coronary Atherosclerosis: AQUARIUS Study Results
- Embargo lift: Tuesday, September 3, 2013 at 11:54 AM
9:00 AM
OPEN TIME SLOT
10:00 AM
10:00 AM – 10:30 AM
- Interviewee: Dr. Chuck Shear
- Topic: The Development of the CSL-112 Study
1:45 PM
1:45 PM – 2:00 PM
- Interviewee: Dr. Bela Merkely and Dr. Toth Attila
- Topic: The EMBRACE-MI Study
2:00 PM
2:00 PM – 2:30 PM
- Interviewee: Dr. Doug Weaver
- Topic: The EMBRACE-MI Study
Monday, September 2, 2013
8:00 AM
8:00 AM – 8:30 AM
- Interviewee: Dr. Nassir Marrouche
- Topic: DECAAF Study: Delayed Enhancement – MRI determinant of successful Catheter Ablation of Atrial Fibrillation: Analysis of post ablation scar and outcome
- Embargo lift: Sunday, September 1, 2013 at 2:36 PM
8:30 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
11:00 AM – 11:30 AM
- Interviewee: Dr. Robert Harrington
- Topic: The Development of the CSL-112 Study
12:30 PM
12:30 PM – 1:00 PM
- Interviewee: Dr. Roxana Mehran
- Topic: PARIS: Incidence and Impact of Dual Antiplatelet Therapy Cessation On Adverse Cardiac Events Following Percutaneous Coronary Intervention: Two-Year Results from the Patterns of Non-Adherence to Anti-Platelet Regimens In Stented Patients (PARIS) Study
- Embargo lift: Sunday, September 1, 2013 at 12:12 PM
1:00 PM
1:00 PM – 1:30 PM
- Interviewee: Dr. Sten Rubertsson
- Topic: LINC study: A multicenter randomized trial comparing a mechanical CPR algorithm using LUCAS vs. manual CPR in out-of-hospital cardiac arrest patients
- Embargo lift: Sunday, September 1, 2013 at 3:12 PM
1:30 PM
1:30 PM – 2:00 PM
- Interviewee: Dr. Ole Frobert
- Topic: TASTE: Thrombus aspiration during ST-segment elevation myocardial infarction. A multicenter, prospective, registry based randomized clinical trial
- Embargo lift: Sunday, September 1, 2013 at 11:18 AM
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Renato Lopes
- Topic: Topic: ESC Wrap-Up in Portuguese
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Basil Lewis
- Topic: Topic: ESC Wrap-Up in Hebrew
3:00 PM
OPEN TIME SLOT
4:00 PM
4:00 PM – 4:30 PM
- Interviewee: Dr. Sergio Leonardi and Professor Diego Ardissino
- Topic: ESC Wrap-Up in Italian
Tuesday, September 3, 2013
8:00 AM
OPEN TIME SLOT
8:30 AM
8:30 AM – 9:00 AM
- Interviewee: Dr. Freek Verheugt
- Topic: ESC Wrap-Up from a Dutch Perspective
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM – 10:30 AM
- Interviewee: Dr. Harry Buller
- Topic: Treatment of venous thromboembolism, the Hokusai VTE Study
- Embargo lift: Sunday, September 1, 2013 at 11:00 AM
10:30 AM
10:30 AM – 11:00 AM
- Interviewee: Dr. Maarten Groenink
- Topic: COMPARE: Effect of losartan on aortic dilatation rate in adults with Marfan Syndrome
- Embargo lift: Monday, September 2, 2013 at 12:12 PM
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:30 PM
12:30 PM – 1:00 PM
- Interviewee: Dr. Shinya Goto
- Topic: ARISTOTLE Sub-Analysis: Efficacy and safety of apixaban compared with warfarin for stroke prevention in atrial fibrillation in East Asia
- Embargo lift: Tuesday, September 3, 2013 at 2:00 PM
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
3:30 PM – 4:00 PM
- Interviewee: Dr. John Teerlink
- Topic: ATOMIC-AHF: Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: Results from ATOMIC-AHF
- Embargo lift: Tuesday, September 3, 2013 at 11:18 AM
4:00 PM
4:00 PM – 4:30 PM
- Interviewee: Dr. Stefan James
- Topic: ESC Wrap-Up from a Scandinavian Perspective
4:30 PM
4:30 PM – 5:00 PM
- Interviewee: Dr. Gilles Montalescot
- Topic: The ACCOAST Trial: A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction
- Embargo lift: Sunday, September 1, 2013 at 2:18 PM
- Interviewee: Dr. Gilles Montalescot
- Topic: ESC Wrap-Up in French